MLA Diagnostics

MLA Diagnostics has developed an integrated multi-parameter risk assessment tool used to identify melanoma patients who based on molecular and clinical risk factors have a high chance of their melanoma spreading or recurring. The molecular assay is easily implemented into current laboratory workflows and enriches clinical and pathological information to support clinicians in clinical decision making and managing their patients treatment.